Viewing Study NCT02942420


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2026-02-25 @ 8:15 PM
Study NCT ID: NCT02942420
Status: UNKNOWN
Last Update Posted: 2017-05-18
First Post: 2016-10-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bucillamine Phase 2 Trial in Patients With Cystinuria
Sponsor: Revive Therapeutics, Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module